The pharma industry in India is expected to grow at a healthy 9-12% over the next five years, as good growth in domestic sales also leads to cardiovascular, anti-diabetic, anti-depressants, and anti-cancers. The focus has been on the rapid introduction of generic drugs in the market and this is expected to benefit Indian pharma companies. Apart from this, emphasis on rural health programs, life-saving drugs, and preventive vaccines also augurs well for pharmaceutical companies. Check out the top 10 pharma companies in India on the India Brand Equity Foundation website. Visit https://www.ibef.org/industry/pharmaceutical-india